Annual report pursuant to Section 13 and 15(d)

Acquisitions - Intangibles Acquired and Weighted Average Useful Life (Details)

v3.20.4
Acquisitions - Intangibles Acquired and Weighted Average Useful Life (Details) - Pfenex
$ in Thousands
Oct. 01, 2020
USD ($)
Business Acquisition [Line Items]  
Approximate Fair Value $ 385,000
Contractual Relationships - Alvogen  
Business Acquisition [Line Items]  
Approximate Fair Value $ 114,000
Estimated useful life (in years) 12 years
Contractual Relationships - Merck  
Business Acquisition [Line Items]  
Approximate Fair Value $ 117,000
Estimated useful life (in years) 12 years
Contractual Relationships - Jazz  
Business Acquisition [Line Items]  
Approximate Fair Value $ 80,000
Estimated useful life (in years) 17 years
Contractual Relationships - SII  
Business Acquisition [Line Items]  
Approximate Fair Value $ 49,000
Estimated useful life (in years) 10 years
Contractual Relationships - Arcellx  
Business Acquisition [Line Items]  
Approximate Fair Value $ 2,000
Estimated useful life (in years) 17 years
Acquired Technologies  
Business Acquisition [Line Items]  
Approximate Fair Value $ 23,000
Minimum | Acquired Technologies  
Business Acquisition [Line Items]  
Estimated useful life (in years) 10 years
Maximum | Acquired Technologies  
Business Acquisition [Line Items]  
Estimated useful life (in years) 19 years